Brief: China Resources Pharmaceutical's Unit Receives Approval For Public Issuance Of Corporate Bonds
17/04/2024 14:23
April 17 (Reuters) - China Resources Pharmaceutical
Group Ltd 3320.HK :
* UNIT RECEIVED APPROVAL REGISTRATION FOR PUBLIC ISSUANCE OF
CORPORATE BONDS BY CR PHARMACEUTICAL COMMERCIAL
* APPROVAL FROM CHINA SECURITIES REGULATORY COMMISSION
* APPROVAL FOR PROPOSED PUBLIC ISSUANCE OF CORPORATE BONDS
IN
AGGREGATE PRINCIPAL AMOUNT OF NOT MORE THAN RMB3 BILLION
Further company coverage: 3320.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Resources Pharmaceutical
See all newsBrief: China Resources Pharmaceutical Group Declares Interim Dividend Of RMB0.087 Per Share
Brief: China Resources Pharmaceutical Says Tasly Pharmaceutical Posts HY Net Profit Attributable Of RMB 892.7 MLN
Brief: China Resources Pharmaceutical Group Says HY Revenue RMB 1.93 Billion For CR Jiangzhong
Brief: China Resources Pharmaceutical Group Posts HY Revenue RMB 1.64 Billion, Down 50.97% For KPC Pharmaceuticals
Brief: China Resources Pharmaceutical Says CR Boya Bio-Pharmaceutical Posts Quarterly Unaudited Revenue RMB 321.1 Million, Net Profit RMB 30.0 Million